These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18276852)

  • 21. The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems.
    Cowen MS; Djouma E; Lawrence AJ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):590-600. PubMed ID: 16014750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.
    Krystal JH; Madonick S; Perry E; Gueorguieva R; Brush L; Wray Y; Belger A; D'Souza DC
    Neuropsychopharmacology; 2006 Aug; 31(8):1793-800. PubMed ID: 16395307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Ray LA; Hutchison KE
    Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of motivational changes on drinking outcomes in pharmacobehavioral treatment for alcohol dependence.
    Penberthy JK; Hook JN; Vaughan MD; Davis DE; Wagley JN; Diclemente CC; Johnson BA
    Alcohol Clin Exp Res; 2011 Sep; 35(9):1694-704. PubMed ID: 21676008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats.
    Landgren S; Simms JA; Hyytiä P; Engel JA; Bartlett SE; Jerlhag E
    Addict Biol; 2012 Jan; 17(1):86-94. PubMed ID: 21309944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial.
    Richter C; Effenberger S; Bschor T; Bonnet U; Haasen C; Preuss UW; Heinz A; Förg A; Volkmar K; Glauner T; Schaefer M
    J Clin Psychopharmacol; 2012 Aug; 32(4):558-62. PubMed ID: 22722516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference.
    Bahi A; Tolle V; Fehrentz JA; Brunel L; Martinez J; Tomasetto CL; Karam SM
    Peptides; 2013 May; 43():48-55. PubMed ID: 23428971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1).
    Santarelli L; Gobbi G; Blier P; Hen R
    J Clin Psychiatry; 2002; 63 Suppl 11():11-7. PubMed ID: 12562138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain activation elicited by affectively positive stimuli is associated with a lower risk of relapse in detoxified alcoholic subjects.
    Heinz A; Wrase J; Kahnt T; Beck A; Bromand Z; Grüsser SM; Kienast T; Smolka MN; Flor H; Mann K
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1138-47. PubMed ID: 17488322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vicarious defeat stress induces increased alcohol consumption in female mice: Role of neurokinin-1 receptor and interleukin-6.
    Decker Ramirez EB; Arnold ME; Schank JR
    Addict Biol; 2024 Jan; 29(1):e13357. PubMed ID: 38221805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effect of 5-hydroxytryptamine 3 and neurokinin 1 receptor antagonism in rodent models of somatic and visceral pain.
    Greenwood-Van Meerveld B; Mohammadi E; Tyler K; Pietra C; Bee LA; Dickenson A
    J Pharmacol Exp Ther; 2014 Oct; 351(1):146-52. PubMed ID: 25077526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of the HPA-axis to alcohol and stress as a function of alcohol dependence and family history of alcoholism.
    Dai X; Thavundayil J; Santella S; Gianoulakis C
    Psychoneuroendocrinology; 2007 Apr; 32(3):293-305. PubMed ID: 17349749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect.
    Vengeliene V; Bachteler D; Danysz W; Spanagel R
    Neuropharmacology; 2005 May; 48(6):822-9. PubMed ID: 15829254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of angiotensin II synthesis inhibition on alcohol consumption].
    Guivernau M; Pallavicini J
    Rev Med Chil; 2008 Aug; 136(8):968-75. PubMed ID: 18949179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting opioid and neurokinin-1 receptors to treat alcoholism.
    Rodriguez FD; Coveñas R
    Curr Med Chem; 2011; 18(28):4321-34. PubMed ID: 21861818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging.
    Mann K; Vollstädt-Klein S; Reinhard I; Leménager T; Fauth-Bühler M; Hermann D; Hoffmann S; Zimmermann US; Kiefer F; Heinz A; Smolka MN
    Alcohol Clin Exp Res; 2014 Nov; 38(11):2754-62. PubMed ID: 25421512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts.
    Muñoz M; Berger M; Rosso M; Gonzalez-Ortega A; Carranza A; Coveñas R
    Int J Oncol; 2014 Jan; 44(1):137-46. PubMed ID: 24190675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutral sphingomyelinase controls acute and chronic alcohol effects on brain activity.
    Wank I; Mittmann C; Kreitz S; Chestnykh D; Mühle C; Kornhuber J; Ludwig A; Kalinichenko LS; Müller CP; Hess A
    Neuropharmacology; 2024 Aug; 253():109948. PubMed ID: 38636728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.